Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 15 - Number 1


Changes of Expression of the Protein C Pathway Components in LPSInduced Endotoxemia–Implication for Sepsis

, 15(1): 2 - 9

Tatsuya Hayashi and Koji Suzuki


DOI: 10.2174/1871529X15666150108110821






Mechanical Ventilation for ARDS Patients – For a Better Understanding of the 2012 Surviving Sepsis Campaign Guidelines

, 15(1): 41 - 45

Muneyuki Takeuchi and Kazuya Tachibana


DOI: 10.2174/1871529X15666150108113853





Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs

, 15(1): 70 - 84

Josefine Hirschfeld and Toshihisa Kawai


DOI: 10.2174/1871529X15666150108115241





Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography
View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

September Health DaysCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog